Informacje dodatkowe
| Use in sports | None |
|---|---|
| Substance class | Prostaglandin analog |
| Side effects | Eye irritation, dry eye, eye redness, growth of eyelashes, darkening of the iris |
| Effects | Reduces intraocular pressure, promotes eyelash growth |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 0.03% solution, one drop in the affected eye(s) once daily |
| Half-life | Approximately 45 minutes in human plasma |
| Main action | Lowers intraocular pressure |
| Formula | C25H37NO4 |
| Water Retention | No significant effect |
| Chemical name | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-5-N-ethylheptenamide |
| Storage conditions | Store at 2В°C to 25В°C (36В°F to 77В°F) |
| Trade name | Lumigan, Latisse |
| Blood pressure | No significant effect on systemic blood pressure |
| Also known as | Lumigan, Latisse when used for eyelash growth |
| Lab Test | Not typically required for monitoring |
| Hepatotoxicity | No known hepatotoxic effects |
| Manufacturer | Sun Pharmaceuticals Industries |
|
Opinie
Na razie nie ma opinii o produkcie.